Alka-Seltzer Plus Severe Cold and Cough PowerFast Fizz
NDC 0280-0023, aspirin, chlorpheniramine maleate, dextromethorphan hydrobromide, phenylephrine bitartrate, tablet, effervescent, from Bayer Healthcare LLC..
- Product NDC
- 0280-0023
- Status
- Listed
- Labeler
- Bayer Healthcare LLC.
- Dosage form
- TABLET, EFFERVESCENT
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE10 mg/1
- ASPIRIN325 mg/1
- CHLORPHENIRAMINE MALEATE2 mg/1
- PHENYLEPHRINE BITARTRATE7.8 mg/1
Pharmacologic classes
Adrenergic alpha1-Agonists [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]; alpha-1 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0280-0023-01 | 00280002301 | 10 POUCH in 1 CARTON (0280-0023-01) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-0023-02 | 00280002302 | 24 POUCH in 1 CARTON (0280-0023-02) / 2 TABLET, EFFERVESCENT in 1 POUCH |
| 0280-0023-03 | 00280002303 | 12 POUCH in 1 CARTON (0280-0023-03) / 2 TABLET, EFFERVESCENT in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0280-0023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0280-0023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.